Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Donatella R.M. Negri"'
Autor:
Chiara Mazzei, Andrea Cara, Andrea Canitano, Donatella R.M. Negri, Martina Borghi, Roberta Bona, Maria Fenicia Vescio, Mary E. Klotman, Zuleika Michelini, Maria Franca Pirillo, Alessandra Gallinaro, Antonio Di Virgilio
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss, Pp 263-275 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development
Integrase-defective lentiviral vectors (IDLVs) represent an attractive platform for vaccine development as a result of the ability to induce persistent humoral- and cellular-mediated immune responses against the encoded transgene. Compared with the p
Autor:
Antonio Di Virgilio, Zuleika Michelini, Andrea Cara, Roberta Bona, Maria Franca Pirillo, Martina Borghi, Alessandra Gallinaro, Serena Cecchetti, Alex Olvera, Donatella R.M. Negri, Christian Brander, Andrea Canitano
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss, Pp 418-428 (2020)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods & Clinical Development
Cellular immune responses play a fundamental role in controlling viral replication and AIDS progression in human immunodeficiency virus (HIV)-infected subjects and in simian immunodeficiency virus (SIV)-infected macaques. Integrase defective lentivir
Autor:
Celia C. LaBranche, Benjamin Mildenberg, Sampa Santra, Andrea Cara, Barton F. Haynes, Erich J Baker, Donatella R.M. Negri, Maria Blasi, Mary E. Klotman, M. Anthony Moody, Wes Rountree, Kevin O. Saunders, Elizabeth C Wescott
Publikováno v:
npj Vaccines, Vol 5, Iss 1, Pp 1-9 (2020)
npj Vaccines
NPJ Vaccines
npj Vaccines
NPJ Vaccines
Despite incredible scientific efforts, there is no cure for HIV infection. While antiretroviral treatment (ART) can help control the virus and prevent transmission, it cannot eradicate HIV from viral reservoirs established before the initiation of th
Autor:
Silvia Baroncelli, Celia C. LaBranche, Robin J. Shattock, Andrea Canitano, Antonella Tinari, Martina Borghi, Rogier W. Sanders, Serena Cecchetti, Maria Blasi, Roberta Bona, Felicia Grasso, Paul F. McKay, Maria Fenicia Vescio, David C. Montefiori, Donatella R.M. Negri, Yoann Aldon, Maria Franca Pirillo, Andrea Cara, Alessandra Gallinaro, Mary E. Klotman, Zuleika Michelini, Gabriella Scarlatti
Integrase Defective Lentiviral Vectors (IDLVs) represent an attractive vaccine platform for delivering HIV-1 antigens, given their ability to induce specific and persistent immune responses in both mice and non-human primates (NHPs). Recent advances
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f798569720a2393992c4de668d0566d3
https://doi.org/10.1101/2021.10.08.462761
https://doi.org/10.1101/2021.10.08.462761
Autor:
Maria Laura De Angelis, Antonella Marchi, Sabrina Mariotti, Valeria Esposito, Paola Di Bonito, Chiara Acchioni, Maria Franca Pirillo, Giulietta Venturi, Maria Vincenza Chiantore, Paul F. McKay, Fabio Tosini, Alessandra Gallinaro, Donatella R.M. Negri, Francesco Marino, Marco Sgarbanti, Andrea Canitano, Fabio Magurano, Roberto Nisini, Antonio Di Virgilio, Antonio Capocefalo, Paola Bucci, Andrea Cara, Angelo Iacobino, Melissa Baggieri, Silvia Sandini, Martina Borghi, Zuleika Michelini, Raffaela Teloni
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
Antibodies targeting Receptor Binding Domain (RBD) of SARS-CoV-2 have been suggested to account for the majority of neutralizing activity in COVID-19 convalescent sera and several neutralizing antibodies (nAbs) have been isolated, characterized and p
Autor:
Elena Bazzigaluppi, Andrea Canitano, Stefania Dispinseri, Lorenzo Piemonti, Andrea Cara, Monica Tolazzi, Cristina Brigatti, Riccardo Vercesi, Gabriella Scarlatti, Vito Lampasona, Paola Cinque, Maria Franca Pirillo, Ilaria Marzinotto, Alessandra Gallinaro, Roberta Caccia, Paul F. McKay, Donatella R.M. Negri, Fabio Ciceri, Martina Borghi
SARS-CoV-2 vaccination is known to induce antibodies that recognize also variants of concerns (VoCs) of the virus. However, epidemiological and laboratory evidences indicate that these antibodies have a reduce neutralization ability against VoCs. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d13919b0943ddbae6b01bc788a81e94
https://doi.org/10.1101/2021.08.15.21262000
https://doi.org/10.1101/2021.08.15.21262000
Autor:
Rossella Canese, Fabrizio Mattei, Laura Bracci, Yves Decadt, Anna Maria Pacca, Eleonora Aricò, Sara Andreone, Giovanna Schiavoni, Filippo Belardelli, Maria Teresa D'Urso, Jacopo Mancini, Maria Ciccolella, Paola Sestili, Daniele Macchia, Thomas SaiYing Ko, Donatella R.M. Negri, Ken Pang
Publikováno v:
Cells
Volume 10
Issue 4
Cells, Vol 10, Iss 845, p 845 (2021)
Volume 10
Issue 4
Cells, Vol 10, Iss 845, p 845 (2021)
Salivary gland tumors are a heterogeneous group of neoplasms representing less than 10% of all head and neck tumors. Among salivary gland tumors, salivary duct carcinoma (SDC) is a rare, but highly aggressive malignant tumor resembling ductal breast
Autor:
Fabio Ciceri, Ilaria Marzinotto, Vito Lampasona, Cristina Brigatti, Martina Borghi, Andrea Cara, Gabriella Scarlatti, Maria Franca Pirillo, Marco Baratella, Maria Laura De Angelis, Francesca Sironi, Elena Bazzigaluppi, Massimiliano Secchi, Giulietta Venturi, Donatella R.M. Negri, Monica Tolazzi, Stefania Dispinseri, Andrea Canitano, Cristina Tresoldi, Lorenzo Piemonti
Understanding how antibody to SARS-CoV-2 evolve during infection may provide important insight into therapeutic approaches to prevent fatal COVID-19 illness and vaccines. Here, we profile the antibody response of 162 well-characterized COVID-19 sympt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2349b0a663e405345d478d40d7e129e4
https://doi.org/10.1101/2021.02.17.21251929
https://doi.org/10.1101/2021.02.17.21251929
Autor:
Antonio Di Virgilio, Valeria Morante, Felicia Grasso, Maria Franca Pirillo, Iole Farina, Alessandra Gallinaro, Andrea Canitano, Martina Borghi, Roberta Bona, Serena Cecchetti, Zuleika Michelini, Andrea Cara, Donatella R.M. Negri
Publikováno v:
Viruses, Vol 13, Iss 355, p 355 (2021)
Viruses
Volume 13
Issue 2
Viruses
Volume 13
Issue 2
Integrase-defective lentiviral vectors (IDLVs) have been used as a safe and efficient delivery system in several immunization protocols in murine and non-human primate preclinical models as well as in recent clinical trials. In this work, we validate
Autor:
Maria Franca Pirillo, Cristina Brigatti, Gabriella Scarlatti, Maria Laura De Angelis, Vito Lampasona, Francesca Sironi, Massimiliano Secchi, Marco Baratella, Lorenzo Piemonti, Andrea Canitano, Giulietta Venturi, Monica Tolazzi, Cristina Tresoldi, Elena Bazzigaluppi, Ilaria Marzinotto, Andrea Cara, Donatella R.M. Negri, Martina Borghi, Fabio Ciceri, Stefania Dispinseri
Publikováno v:
Nature communications
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Understanding how antibody responses to SARS-CoV-2 evolve during infection may provide important insight into therapeutic approaches and vaccination for COVID-19. Here we profile the antibody responses of 162 COVID-19 symptomatic patients in the COVI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01bb8d63863c090433c011f63be5ca27